These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


104 related items for PubMed ID: 21797803

  • 21. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
    Zieglmayer P, Zieglmayer R, Bareille P, Rousell V, Salmon E, Horak F.
    Curr Med Res Opin; 2008 Jun; 24(6):1833-40. PubMed ID: 18498678
    [Abstract] [Full Text] [Related]

  • 22. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis.
    Storms WW.
    J Asthma; 1998 Jun; 35(4):313-36. PubMed ID: 9669826
    [Abstract] [Full Text] [Related]

  • 23. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis.
    Lumry WR.
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):S150-8. PubMed ID: 10518812
    [Abstract] [Full Text] [Related]

  • 24. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis.
    Bernstein DI, Levy AL, Hampel FC, Baidoo CA, Cook CK, Philpot EE, Rickard KA.
    Clin Exp Allergy; 2004 Jun; 34(6):952-7. PubMed ID: 15196285
    [Abstract] [Full Text] [Related]

  • 25. Nasal cytological changes following pharmacological intervention.
    Meltzer EO.
    Allergy; 1995 Jun; 50(23 Suppl):15-20. PubMed ID: 7604949
    [Abstract] [Full Text] [Related]

  • 26. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis.
    Banov CH, Woehler TR, LaForce CF, Pearlman DS, Blumenthal MN, Morgan WF, Frazer H, Southern DL, Gold B, Field E.
    Ann Allergy; 1994 Sep; 73(3):240-6. PubMed ID: 8092559
    [Abstract] [Full Text] [Related]

  • 27. [Fluticasone propionate--a new name common in asthma and rhinitis].
    Ulmeanu R, Mihălţan F.
    Pneumoftiziologia; 1997 Sep; 46(1):63-4. PubMed ID: 9289240
    [No Abstract] [Full Text] [Related]

  • 28. Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance.
    Berger WE, Godfrey JW, Slater AL.
    Expert Opin Drug Deliv; 2007 Nov; 4(6):689-701. PubMed ID: 17970670
    [Abstract] [Full Text] [Related]

  • 29. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis.
    Máspero JF, Rosenblut A, Finn A, Lim J, Wu W, Philpot E.
    Otolaryngol Head Neck Surg; 2008 Jan; 138(1):30-7. PubMed ID: 18164990
    [Abstract] [Full Text] [Related]

  • 30. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis.
    Bryson HM, Faulds D.
    Drugs; 1992 May; 43(5):760-75. PubMed ID: 1379151
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk.
    Meltzer EO, Lee J, Tripathy I, Lim J, Ellsworth A, Philpot E.
    Pediatr Allergy Immunol; 2009 May; 20(3):279-86. PubMed ID: 18680490
    [Abstract] [Full Text] [Related]

  • 32. Topical nasal sprays: treatment of allergic rhinitis.
    Kobayashi RH, Kiechel F, Kobayashi AL, Mellion MB.
    Am Fam Physician; 1994 Jul; 50(1):151-7, 161-2. PubMed ID: 7517094
    [Abstract] [Full Text] [Related]

  • 33. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults.
    Zeng M, Long XB, Cui YH, Liu Z.
    Am J Rhinol Allergy; 2011 Jul; 25(6):e203-7. PubMed ID: 22185725
    [Abstract] [Full Text] [Related]

  • 34. New treatments for allergic rhinitis.
    Tkachyk SJ.
    Can Fam Physician; 1999 May; 45():1255-60. PubMed ID: 10349070
    [Abstract] [Full Text] [Related]

  • 35. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.
    Craig TJ, Mende C, Hughes K, Kakumanu S, Lehman EB, Chinchilli V.
    Allergy Asthma Proc; 2003 May; 24(1):53-8. PubMed ID: 12635578
    [Abstract] [Full Text] [Related]

  • 36. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms.
    Baroody FM, Logothetis H, Vishwanath S, Bashir M, Detineo M, Naclerio RM.
    Am J Rhinol Allergy; 2013 Jan; 27(1):48-53. PubMed ID: 23406601
    [Abstract] [Full Text] [Related]

  • 37. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA.
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
    Stokes M, Amorosi SL, Thompson D, Dupclay L, Garcia J, Georges G.
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
    [Abstract] [Full Text] [Related]

  • 39. A comparison of the clinical efficacy and safety of intranasal fluticasone propionate and antihistamines in the treatment of rhinitis.
    Foresi A.
    Allergy; 2000 Sep; 55 Suppl 62():12-4. PubMed ID: 10929863
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M, Akiyama K, Mori N.
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.